glp-1/gcgr dual agonist Media Centre Mazdutide: An emerging glucagon/GCG-like peptide-1
Description
Eli Lilly and Novartis (speakers bureau
He has worked on diverse projects in microbiology, biopolymers, and drug delivery
If cost is a central factor, the Medicare program may have a big impact
Spencer JP, Thomas S, Trondsen Pawlowski RH
Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial
